ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Nerivio Receives Expanded Indication to Cover Chronic Migraine Patients
November 02, 2020Theranica announced its Nerivio® medical device has received U.S. Food and Drug Administration (FDA) clearance for an expanded indication encompassing acute treatment of chronic migraine in people 18 years and older. -
Lilly Announces Positive Results for Three Phase 3 Studies of Galcanezumab for the Prevention of Epi
May 15, 2017Eli Lilly and Company (NYSE: LLY) announced that galcanezumab, an investigational treatment for the prevention of episodic and chronic migraine met its primary endpoint...
Pharma Sources Insight January 2025
